From: Predicting early postoperative PONV using multiple machine-learning- and deep-learning-algorithms
PONV | No | Yes | P-value |
---|---|---|---|
Number | 2279 | 338 | |
Age [years] | 61.0 ± 13.2 | 59.9 ± 14.4 | 0.265 |
Sex | < 0.001 | ||
Male | 1269 (55.7%) | 109 (32.2%) | |
Female | 1010 (44.3%) | 229 (67.8%) | |
Smoking | 0.216 | ||
No | 1916 (84.1%) | 293 (86.7%) | |
Yes | 363 (15.9%) | 45 (13.3%) | |
Haloperidol | 0.617 | ||
No | 1167 (51.2%) | 178 (52.7%) | |
Yes | 1112 (48.8%) | 160 (47.3%) | |
History.PONV | 0.004 | ||
No | 2231 (97.9%) | 322 (95.3%) | |
Yes | 48 (2.1%) | 16 (4.7%) | |
Combined.Anesthesia | < 0.001 | ||
No | 1284 (56.3%) | 117 (34.6%) | |
Yes | 995 (43.7%) | 221 (65.4%) | |
Sufentanil.Epidural | < 0.001 | ||
0 μg | 1350 (59.4%) | 125 (37.0%) | |
10 μg | 909 (40.0%) | 206 (60.9%) | |
20 μg | 12 (0.5%) | 7 (2.1%) | |
Piritramide [mg] | 2.9 ± 5.9 | 4.4 ± 7.9 | < 0.001 |
Anesthesia.Duration [min] | 177.2 ± 85.9 | 229.6 ± 96.2 | < 0.001 |
Sufentanil.Infusion [μg/h] | 0.4 ± 4.6 | 0.4 ± 4.0 | 0.715 |
Sufentanil.Bolus [μg] | 33.6 ± 26.5 | 34.2 ± 27.3 | 0.681 |
Sufentanil.TCI [μg] | 1.9 ± 12.6 | 2.8 ± 19.5 | 0.548 |
Remifentanil.Infusion [μg/h] | 166.7 ± 358.2 | 170.8 ± 368.7 | 0.952 |
Remifentanil.Bolus [μg] | 0.5 ± 7.6 | 0.4 ± 6.5 | 0.572 |
Remifentanil.TCI [μg] | 251.5 ± 685.7 | 350.0 ± 832.1 | 0.230 |